Clinical Trial Update: Effects of Atorvastatin in Graves' Orbitopathy (GO) [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the effects of atorvastatin in Graves' orbitopathy (thyroid-associated ophthalmopathy) and hypercholesterolemia; study completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Orbitopathy
• Hypercholesterolemia
• Thyroid-associated Ophthalmopathy

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: University of Pisa | Conditions: Thyroid Associated Ophthalmopathy, Hypercholesterolemia | Phase 2 | Status: COMPLETED